Delcath Systems, Inc. (DCTH)

NASDAQ: DCTH · USD

$14.9

+0.11 (+0.8%)· Recorded snapshot

Market cap	515.6M
Revenue (ttm)	95.4M
Net income (ttm)	532K
EPS (ttm)	$0.01
Shares out	34.7M
P/E (trailing)	1010.9x
Volume	258,811
Beta	0.60

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 95.4M
Net income (ttm): 532K
EPS (ttm): $0.01
P/E (trailing): 1010.9x
Market cap: 515.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/E1,010.9

P25 15.4P50 25.8P75 43.5

ROE0.5

P25 -113.8P50 -46.5P75 -0.9

ROIC-2.9

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All DCTH indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000872912
Company name	Delcath Systems, Inc.
Country	United States
Country code	US
CUSIP number	24661P807
Earnings date	2026-11-09
Earnings time	bmo
Employees	156
Employees change	60
Employees growth	62.5%
Enterprise value	$422.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1988
In index	RUSSELL2000
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US24661P8077
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2019-12-24
Last stock split type	Reverse
Market cap	$515.6M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$14.86
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	DCTH
U.S. state	New York
Website	https://www.delcath.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	1,486x
Earnings yield	0.1%
EV/Earnings	786.41x
EV/FCF	23.9x
EV/Sales	4.38x
FCF / EV yield	4.18%
FCF yield	3.42%
Forward EV/Sales	3.47x
Forward P/S	4.25x
Graham number	1.07557
Graham upside	-92.71%
Industry forward P/E	19.81x
Industry P/E	39.5x
P/B ratio	4.22x
P/E ratio	1,010.88x
P/FCF ratio	29.23x
P/OCF ratio	26.13x
P/S ratio	5.36x
Price / tangible book value	4.22x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-1.9%
EBITDA margin	-1.52%
Effective tax rate	58.82%
FCF margin	18.35%
Gross margin	87.05%
Operating margin	-1.9%
Pretax margin	1.35%
Profit margin	0.56%
Profit per employee	$3,410
Profitable quarters	1
Profitable years	1
Revenue per employee	$611,654
ROA	-0.89%
ROA (5Y)	-45.16%
ROCE	-1.47%
ROE	0.47%
ROE (5Y)	-404.25%
ROIC	-2.87%
ROIC (5Y)	-1,231.53%
SBC / revenue	21.2%
Tax / revenue	0.8%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-71.87%
EPS growth (Q)	0%
EPS growth years	3
FCF growth	352.73%
FCF growth (Q)	-24.45%
FCF growth (QoQ)	1,714.98%
Gross profit growth	37.72%
Gross profit growth (Q)	25.48%
Gross profit growth 3Y	256.45%
Gross profit growth 5Y	133.76%
Net income growth	-76.17%
Net income growth (Q)	-1.08%
Net income growth years	2
OCF growth	303.9%
OCF growth (Q)	-21.68%
OCF growth (QoQ)	566.51%
Operating income growth (Q)	-7.53%
Revenue growth	35.85%
Revenue growth (Q)	20.6%
Revenue growth (QoQ)	16.56%
Revenue growth 10Y	49.45%
Revenue growth 3Y	230.76%
Revenue growth 5Y	118.91%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.1M
Depreciation and amortization	$359,000
EBIT	$-1.8M
EBITDA	$-1.5M
EPS	$0.01
FCF per share	$0.50
Financing cash flow	$-4.3M
Free cash flow	$17.5M
Free cash flow minus SBC	$-2.7M
Gross profit	$83.1M
Income taxes	$760,000
Investing cash flow	$-2.1M
Net cash flow	$13.1M
Net income	$532,000
Operating cash flow minus SBC	$-635,000
Operating income	$-1.8M
Revenue	$95.4M
Stock-based compensation	$20.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	10.04
Book value per share	$3.50
Debt / equity	0.02
Debt / FCF	0.14
Long-term assets	$6.5M
Long-term liabilities	$2.6M
Net cash (debt)	$93.4M
Net cash / market cap	18.26%
Net cash growth	16.78%
Net debt / equity	-0.77
Net debt / FCF	-5.34
Piotroski F-Score	4
Property, plant and equipment	$6.5M
Shareholders' equity	$121.1M
Tangible book value	$121.1M
Tangible book value per share	$3.50
Total assets	$137M
Total cash	$95.9M
Total debt	$2.5M
Total liabilities	$15.9M
WACC	7.5%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.75
Current assets	$130.5M
Current liabilities	$13.3M
Current ratio	9.83
Inventory turnover	1.11
Net working capital	$21.6M
Quick ratio	8.45
Working capital	$117.3M
Working capital turnover	0.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-13.16%
Dividend yield	0%
Shareholder yield	-13.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-100%
10Y return CAGR	-81.23%
10Y total return	-100%
150-day SMA	$13.19
1D price change	0.75%
1M price change	-4.74%
1M total return	-4.74%
1W price change	1.09%
1W total return	1.09%
1Y price change	48.75%
1Y return CAGR	48.79%
1Y total return	48.75%
20-day SMA	$14.97
200-day SMA	$12.30
3M price change	24.46%
3M total return	24.46%
3Y price change	353.05%
3Y return CAGR	65.45%
3Y total return	353.05%
50-day SMA	$15.77
50-day SMA vs 200-day SMA	50over200
52-week high	$17.42
52-week high date	2026-08-11
52-week low	$8.12
52-week low date	2025-11-20
5Y price change	38.62%
5Y return CAGR	6.75%
5Y total return	38.62%
6M price change	37.09%
6M total return	37.09%
All-time high	$8,980,000,000.00
All-time high date	2014-04-10
All-time low	$2.25
All-time low date	2023-11-14
Average true range (ATR)	$0.47
Average volume	302.8K
Beta (1Y)	1.69
Beta (2Y)	1.7
Beta (5Y)	0.6
Change from 52-week high	-14.7%
Change from 52-week low	83.01%
Change from all-time high	-100%
Change from all-time low	560.44%
Change from open	0.41%
Day's gap	0.34%
Dollar volume	$3.8M
High price	$14.88
Low price	$14.69
Monthly RSI	16.88
Open price	$14.80
Position in 52-week range	89.47%
Premarket change	1.7%
Premarket close	$14.75
Premarket price	$15.00
Premarket volume	6.2K
Previous close	$14.75
Price vs 150-day SMA	12.7%
Price vs 20-day SMA	-0.71%
Price vs 200-day SMA	20.79%
Price vs 50-day SMA	-5.75%
Relative volume	0.86
RSI	46.62
Sharpe ratio	0.96
Sharpe ratio (3Y)	1.02
Sharpe ratio (5Y)	0.37
Sortino ratio	1.76
Sortino ratio (3Y)	1.81
Sortino ratio (5Y)	0.78
Volume	258.8K
Weekly RSI	56.97
YTD price change	47.13%
YTD total return	47.13%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25.5M
Float percentage	73.56%
Shares change (QoQ)	10.38%
Shares change (YoY)	13.16%
Shares held by insiders	7.17%
Shares held by institutions	41.49%
Shares outstanding	34.7M
Short % of float	7.63%
Short % of shares	5.61%
Short ratio	5.5 days

Deeper analysis on DCTH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DCTH report

Is a complete DCTH research report available?

No complete published report is available for Delcath Systems, Inc. (DCTH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Delcath Systems, Inc. (DCTH)

Price

Financial snapshot

Fair-value bridge

Latest news · DCTH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DCTH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DCTH

Frequently asked questions